MYnd Analytics Inc (MYND):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MYnd Analytics Inc (MYND) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9842
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychiatric EEG Evaluation Registry (PEER) Online, a cloud-based platform that enables physicians to exchange outcome data for patients referenced to neurophysiology data gathered using a standard electroencephalogram (EEG). MYnd Analytics offers reference data and analytics tools for clinicians and researchers through the company’s psychiatric EEG evaluation registry or PEER online. It serves healthcare professionals across the US. MYnd Analytics is headquartered in Mission Viejo, California, the US.

MYnd Analytics Inc (MYND) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYnd Analytics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MYnd Analytics Inc, Medical Devices Deals, 2012 to YTD 2018 9
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
CNS Response Raises US$0.3 Million In Venture Financing 11
Equity Offering 12
MYnd Analytics Raises USD2.1 Million in Private Placement of Common Shares 12
MYnd Analytics Raises USD8.8 Million in Public Offering of Shares 13
MYnd Analytics Raises USD0.2 Million in Private Placement of Shares 15
MYnd Analytics Raises USD0.3 Million in Priavte Placement of Shares 16
MYnd Analytics to Raise USD10 Million in Private Placement of Shares 17
MYnd Analytics Raises USD1 Million in Private Placement of Shares 18
CNS Response Completes Second Tranche Of Private Placement Of Shares For US$2 Million 19
CNS Response Completes Private Placement Of Shares For US$2 Million 20
MYnd Analytics Inc – Key Competitors 22
MYnd Analytics Inc – Key Employees 23
MYnd Analytics Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Other Significant Developments 25
Aug 22, 2018: Mynd Analytics invited to present at the 2018 military health system research symposium 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYnd Analytics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYnd Analytics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
MYnd Analytics Inc, Medical Devices Deals, 2012 to YTD 2018 9
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CNS Response Raises US$0.3 Million In Venture Financing 11
MYnd Analytics Raises USD2.1 Million in Private Placement of Common Shares 12
MYnd Analytics Raises USD8.8 Million in Public Offering of Shares 13
MYnd Analytics Raises USD0.2 Million in Private Placement of Shares 15
MYnd Analytics Raises USD0.3 Million in Priavte Placement of Shares 16
MYnd Analytics to Raise USD10 Million in Private Placement of Shares 17
MYnd Analytics Raises USD1 Million in Private Placement of Shares 18
CNS Response Completes Second Tranche Of Private Placement Of Shares For US$2 Million 19
CNS Response Completes Private Placement Of Shares For US$2 Million 20
MYnd Analytics Inc, Key Competitors 22
MYnd Analytics Inc, Key Employees 23
MYnd Analytics Inc, Subsidiaries 24

List of Figures
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MYnd Analytics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[MYnd Analytics Inc (MYND):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jubilee General Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Simons Group Ltd:企業の戦略・SWOT・財務情報
    Simons Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Simons Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Oriental Hotels Ltd:企業の戦略・SWOT・財務分析
    Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cancer Genetics Inc (CGIX):企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostic products and services enabling precision medicine in the field of oncology. It offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. The company's oncology tests and laboratory ser …
  • Finnair Oyj:戦略・SWOT・企業財務分析
    Finnair Oyj - Strategy, SWOT and Corporate Finance Report Summary Finnair Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Recordati Rare Diseases Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Recordati Rare Diseases Inc (RRD), a subsidiary of Recordati SpA is a biopharmaceutical company that discovers and develops orphan drugs and biologics. The company’s products comprise chemet, neoprofen, panhematin, desoxyn, mustargen, carbaglu, cosmegen, peganone and tranxene, among others. …
  • Pacgen Life Science Corp (PBS):企業の財務・戦略的SWOT分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp, is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. It provides product such as include amino-a …
  • The Bank Of East Asia, Limited:企業の戦略・SWOT・財務分析
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ALung Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary ALung Technologies Inc (ALung Technologies) is a medical device company that develops devices for treating patients with acute respiratory failure. The company's Hemolung Respiratory Assist System(RAS) provides respiratory dialysis that removes carbon dioxide and delivers oxygen directly to …
  • Monsanto Company:企業の戦略・SWOT・財務分析
    Monsanto Company - Strategy, SWOT and Corporate Finance Report Summary Monsanto Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Taylor-DeJongh Inc:企業の戦略・SWOT・財務分析
    Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report Summary Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Immunovia AB (IMMNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Bactiguard Holding AB (BACTI B):医療機器:M&Aディール及び事業提携情報
    Summary Bactiguard Holding AB (Bactiguard) is a medical device manufacturer which develops and supplies infection protection solutions and antibiotics. The company’s product portfolio includes urinary catheters, foley catheters (BIP Foley catheters), endotracheal tubes and central venous catheters. …
  • Egmont International Holding AS:企業の戦略的SWOT分析
    Egmont International Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Nayara Energy Ltd:企業の戦略的SWOT分析
    Nayara Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Bose Corporation:企業の戦略・SWOT・財務情報
    Bose Corporation - Strategy, SWOT and Corporate Finance Report Summary Bose Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd, is an upstream oil and gas exploration and production company. The company explores, produces, and develops, oil and gas properties in Trinidad and Tobago. It holds interests in projects such as South Palo Seco, New …
  • KB Home:企業の戦略・SWOT・財務分析
    KB Home - Strategy, SWOT and Corporate Finance Report Summary KB Home - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Oil States International, Inc. (OIS)-石油・ガス分野:企業M&A・提携分析
    Summary Oil States International, Inc. (Oil States) is an oilfield services company. It offers specialty products and services to oil and natural gas companies. The company’s product portfolio includes subsea equipment and offshore vessel, rig equipment, flexible bearings, connection systems, subsea …
  • Albireo Pharma Inc (ALBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆